Crowdfunding the Cure
Conquering the negative effects of aging is one of the oldest dreams of humanity, and now, through the steady progress of science, we are poised to fulfill that dream.
Whether this occurs in 20 years or 200 is largely a question of funding. The best way to accelerate this process is by mobilizing those who desire the option of a longer and healthier life into a cohesive social force – crowdfunding relevant research and advocating for its benefits to society.
WHAT IS LIFESPAN.IO?
Lifespan.io is a unique crowdfunding platform dedicated solely to longevity research projects. By crowdfunding early-stage studies on aging, we are contributing to the faster accumulation of knowledge on how to prevent and eventually reverse age-related ill health, and help new therapies reach clinical trials sooner.
Researchers can launch breakthrough projects that might be overlooked by the government grant system due to their novel nature, receiving funds from contributors to fulfill their goals.
Contributors, in turn, can influence the direction and pace of the scientific research that is important to them personally, whilst receiving useful rewards and learning more about the exciting field of rejuvenation biotechnology.
Since Lifespan.io was launched in 2015, we have raised over $200,000 for breakthrough research and hosted the following successful crowdfunding campaigns.
With support from Heroes like you, we can keep improving Lifespan.io, support more important studies, and offer unique experiences to you and the longevity community.
Ongoing patrons campaign.
Designing better systems for the detection and safe removal of dysfunctional “senescent” cells to improve health and treat age-related diseases.
High-throughput screening of a library of diverse drugs to find treatments for “ALT” cancers, those which rely on Alternative Lengthening of Telomeres to grow and spread.
Testing a new class of compounds, senolytics, on their ability to extend healthy lifespan by clearing out dysfunctional cells in the body at the University of Leipzig.
Engineering backup copies of mitochondrial genes to place in the nucleus of the cell, aiming to prevent age-related damage and restore lost mitochondrial function.